U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07208526) titled 'A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST' on Sept. 28.
Brief Summary: This project aims to conduct a prospective, multicenter, randomized controlled clinical trial. The study plans to enroll 270 patients with locally advanced iCCA who have successfully undergone GOLP conversion therapy. Participants will be randomized at a 1:2:2 ratio into three arms: Control Arm (continued medication), Direct Surgery Arm, and TDTP-RECIST Assessment Arm. The primary endpoint is Overall Survival (OS).
Study Start Date: Dec. 01
Study Type: INTERVENTIONAL
Condition:
Intrahepatic Cholangiocarcinoma (Icc)
Conversion Therapy...